Investor directory

HQ Capital

HQ Capital is an independent investment manager focusing on private equity and real estate. With a global platform, it delivers client-specific investment solutions through experienced teams in Europe, North America and Asia. Formed in 2015 from the consolidation of Auda, Real Estate Capital Partners and Equita, the firm has a long-standing presence in private equity and U.S. real estate and continues to expand in the German-speaking region. HQ Capital emphasizes aligning its interests with clients and leveraging its network to pursue opportunities, and manages more than US$12 billion in assets across its private equity and real estate activities.
http://hqcapital.com
https://crunchbase.com/organization/hq-capital
https://linkedin.com/company/hq-capital
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=95213
https://www.privateequityinternational.com/database/#/profile?id=1470

Jacob Chiu

Managing Director, Head of Asian Investments and Member of the Executive Committee

Amit Dabas

Director

Michael Hu

Managing Director and Executive Committee Member

Patrick Knoefler

Managing Director and Executive Committee Member

Britta Lindhorst

Managing Director, Head of European Investments and Global Head of ESG / Impact

Oliver Schlümer

Director

Kenneth Ward-Smith

Managing Director

Stephen Wesson

Managing Director, General Partner, Executive Committee Member and Investment Committee Member

Benjamin Wilson

Managing Director and Executive Committee Member

Lucian Wu

Managing Director

Lily Young

Associate

1 past transactions

Interlace Medical

Series C in 2009
Interlace Medical, Inc. specializes in designing and developing medical devices tailored for interventional gynecologists. The company's primary focus is on creating innovative solutions for office-based procedures that address gynecological diseases and conditions that have historically necessitated surgical intervention in operating rooms. Among its notable products is the MyoSure hysteroscopic tissue removal system, which is specifically designed for the removal of submucosal fibroids and polyps. Through its advancements, Interlace Medical aims to enhance the efficiency and effectiveness of gynecological treatments, thereby improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.